Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UHS
UHS logo

UHS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Universal Health Services Inc (UHS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
141.170
1 Day change
-0.06%
52 Week Range
246.320
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Universal Health Services Inc (UHS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has potential for modest short-term gains, the lack of significant positive catalysts, bearish technical indicators, and mixed analyst sentiment suggest holding off on immediate investment. The investor's funds may be better allocated to assets with clearer growth prospects and stronger support for long-term appreciation.

Technical Analysis

The technical indicators for UHS are currently bearish. The MACD is above 0 but positively contracting, suggesting weakening bullish momentum. The RSI is neutral at 28.95, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot point of 144.461, with key support at 141.214 and resistance at 147.708.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The options data indicates a bullish sentiment with a low put-call ratio in terms of volume, but the open interest ratio suggests a more balanced outlook.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
1

Positive Catalysts

  • No significant positive catalysts identified. The stock has a 70% chance to gain 6.42% in the next month based on historical candlestick patterns.

Neutral/Negative Catalysts

  • Analyst sentiment is mixed, with several firms lowering price targets and expressing concerns about core growth acceleration. The stock's valuation is seen as justified due to Medicaid DPP exposure and slower growth. No recent news or congressional trading data to support a bullish case.

Financial Performance

No financial data available for analysis. The company's Q1 results were in line with expectations but left limited near-term upside, as per analyst commentary.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed, with price targets ranging from $165 to $310. While some analysts maintain a Buy rating, others have downgraded the stock or expressed concerns about its ability to achieve growth targets.

Wall Street analysts forecast UHS stock price to rise
15 Analyst Rating
Wall Street analysts forecast UHS stock price to rise
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 141.260
sliders
Low
190
Averages
248
High
302
Current: 141.260
sliders
Low
190
Averages
248
High
302
Wells Fargo
Equal Weight
initiated
$165
AI Analysis
2026-06-01
Reason
Wells Fargo
Price Target
$165
AI Analysis
2026-06-01
initiated
Equal Weight
Reason
Wells Fargo resumed coverage of Universal Health with an Equal Weight rating and $165 price target. The firm's 2026 EBITDA estimate is unchanged, but 2027 EBITDA estimated is down 3.6% on lower core growth. While valuation is well below average, Wells sees as justified by Medicaid DPP exposure and core growth acceleration required.
UBS
Buy
to
Buy
downgrade
$320 -> $310
2026-04-30
Reason
UBS
Price Target
$320 -> $310
2026-04-30
downgrade
Buy
to
Buy
Reason
UBS lowered the firm's price target on Universal Health to $310 from $320 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UHS
Unlock Now

People Also Watch